IBP
Installed Building Products, Inc.
IBP has lower modeled downside risk, despite its lower overall score.
TSLA
Tesla, Inc.
TSLA has the edge over IBP overall, supported by stronger modeled upside.
IBP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Healthy |
IBP's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
IBP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $151 | -33% |
| Fair | 24x | $214 | -4.3% |
| Forward | 24x | $224 | — |
| Current | 26x | $224 | — |
| Expensive | 33x | $292 | +31% |
Historical ranges are pointers, not guarantees.
IBP has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
IBP Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect IBP's earnings and profitability to decline, with its revenue holding steady.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
TSLA has the edge over IBP on the outlook, with more favorable earnings and revenue expectations.
IBP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.38 | +6.9% |
| Q3 2026 | $8.77 | -5.6% |
| Q2 2026 | $9.27 | +3.1% |
| Q1 2026 | $9.36 | +6.7% |
| Q4 2025 | $9.71 | +6.7% |
| Q3 2025 | $9.29 | +3.2% |
| Q2 2025 | $8.99 | +0.3% |
| Q1 2025 | $8.77 | -0.8% |
| Q4 2024 | $9.10 | +5.7% |
IBP has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
IBP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $808.4M | +3.9% |
| Q2 2026 | $777.8M | +2.3% |
| Q1 2026 | $660.5M | -3.5% |
| Q4 2025 | $747.5M | -0.4% |
| Q3 2025 | $778.2M | +2.3% |
| Q2 2025 | $760.3M | +3.1% |
| Q1 2025 | $684.8M | -1.2% |
| Q4 2024 | $750.2M | +4.1% |
IBP has the edge over TSLA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -2.4 points |
| Q2 2026 | 12% | -1.1 points |
| Q1 2026 | 8.7% | -1.5 points |
| Q4 2025 | 15% | +1.4 points |
| Q3 2025 | 14% | +0.4 points |
| Q2 2025 | 13% | +0.4 points |
| Q1 2025 | 10% | -2.5 points |
| Q4 2024 | 13% | -0.4 points |
IBP has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
IBP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $58.3M | -44% |
| Q2 2026 | $51.9M | -31% |
| Q1 2026 | $85.7M | +19% |
| Q4 2025 | $49.3M | -6.8% |
| Q3 2025 | $104.8M | +36% |
| Q2 2025 | $74.8M | +29% |
| Q1 2025 | $71.9M | +14% |
| Q4 2024 | $52.9M | -29% |
IBP has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
IBP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -206K shares |
| 1 year | -2.5% | -666K shares |
| 3 years | -6.4% | -1.8M shares |
| 5 years | -11% | -3.1M shares |
| Available history | -11% | -3.4M shares |
IBP has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $76.3M |
| Q1 2026 | $25.4M |
| Q4 2025 | $37.7M |
| Q3 2025 | $51.4M |
| Q2 2025 | $49.2M |
| Q1 2025 | $34.3M |
| Q4 2024 | $78.9M |
IBP spent $139M buying back its own shares over the past year, down 35% from the year before.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
IBP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 1.6x | Healthy |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.3x | Healthy |
| Q1 2025 | 1.4x | Healthy |
| Q4 2024 | 1.3x | Healthy |
IBP's net debt is about 1.5 years of its operating earnings (EBITDA), up from 1.3 years a year ago.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over IBP on leverage, with a lower net debt burden relative to earnings.
IBP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.4 | Neutral |
| Stochastic | 55.5 | Neutral |
IBP's weekly RSI is 50 (neutral) and its Stochastic is 55 (neutral).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
IBP PE vs Consumer Cyclical Sector
| Metric | IBP | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 18x | 42% above |
| PE % | 52 | 47 | 5 pts above |
IBP has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
IBP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $202.6 | 10% above |
| 20 week MA | $218.5 | 2.4% above |
| 50 week MA | $249.9 | 10% below |
| 100 week MA | $227.4 | 1.6% below |
| 200 week MA | $201.6 | 11% above |
IBP's trend is mixed: it's above three of its five weekly moving averages, and 11% above its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over IBP on trend strength, trading above more of its moving averages.
IBP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $69.1 | $108.7 | +57% |
| 2021 | $108.7 | $139.0 | +28% |
| 2022 | $139.0 | $87.5 | -37% |
| 2023 | $87.5 | $182.8 | +109% |
| 2024 | $182.8 | $174.3 | -4.6% |
| 2025 | $174.3 | $267.2 | +53% |
| 2026 YTD | $267.2 | $223.8 | -16% |
IBP has the edge over TSLA on returns for 2026, with the stronger performance.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA's yearly returns have swung widely, from +669% in 2020 to −65% in 2022. It's down 16% so far in 2026.